Overview

A Comparison of Antiplatelet Therapies in Asian Subjects With Acute Coronary Syndrome

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The study will compare the safety and efficacy of prasugrel, administered at different doses with clopidogrel in the treatment of Asian participants with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
Daiichi Sankyo Co., Ltd.
Treatments:
Clopidogrel
Prasugrel Hydrochloride
Ticlopidine